← Eichor
Study identifier: NCT07526311 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Reducing Blood Loss During Myomectomy:Uterine Artery Ligation Vs Pericervical Tourniquet

Condition: Myoma;Uterus · Blood Loss  ·  Sponsor: Cairo University

PhaseNA
Planned participants40
Who can joinFemale, 25 Years to 48 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to compare two surgical techniques for reducing blood loss during transabdominal myomectomy in women with symptomatic uterine fibroids. The main question it aims to answer is whether bilateral uterine artery ligation reduces intraoperative blood loss more effectively than pericervical mechanical tourniquet application, without increasing operative complications. Researchers will compare bilateral uterine artery ligation with pericervical mechanical tourniquet application during open myomectomy to evaluate blood loss and surgical safety. Participants will undergo elective transabdominal myomectomy and will be randomly assigned to one of the two vascular control techniques before myoma enucleation.

This description comes directly from the study's public registry record.

Talk to the study team

Maged Elmohamady Rashedy, MD  ·  01090013685  ·  Magedalmohamady50@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Cairo UniversityCairo, Al-Manial, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07526311